HEC137076

N/A

Report date: 2025/02/25 11:17:54
NME

Base Information

Drug NameHEC137076
Drug Alias NameHEC137076MsOHHEC-137076HEC137076
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1f (5-HT1f) receptor inhibitors
TargetsSerotonin 1f (5-HT1f) receptor
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuangdong Dongyangguang Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGuangdong Dongyangguang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsMigraine Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A